Granville and Baird Capital have sold Amoena Group to Halder

The global leader in breast prosthetics, Amoena Group (“Amoena” or the “Company”), headquartered in Raubling, Germany, has been sold by funds advised by Granville and Baird Capital through a management buyout to Halder. Amoena’s management will remain as shareholders.

Established in 1975, the Company is the global leader in high-quality silicone breast prosthetics and complementary functional apparel (lingerie, swimwear and sportswear) for women after a mastectomy. Within a multi-channel distribution concept, key sales channels include medical supply stores, hospitals, department stores and boutiques. Worldwide, Amoena employs a staff of 700. Over the next years, the company plans to increase sales of the functional sportswear and leisurewear segment (shirts, tops, nightwear and wellness apparel).

Granville is an independent private equity firm which focuses on investments in mid-market companies in Germany.

Baird Capital is the equity investment arm of Robert W. Baird & Co. and invests globally in venture capital, growth capital and private equity. Baird Capital has raised and managed more than USD 3 billion in capital and invested in more than 275 companies since 1989.

Halder has been active in Germany since 1991 and has provided 37 mid-cap companies with financing for succession and growth. Its current fund, Halder-GIMV Germany II, has so far invested in eight mid-cap firms in total.

The terms of the transaction were not disclosed.

Lincoln International was mandated by the shareholders of Amoena as exclusive financial advisor for the sales process.

Granville and Baird have sold Amoena to Hadler 2014
  • 2014
    Close Year
  • Consumer | Healthcare
    Industry
  • Private Equity
    Client Type
  • Financial | Cross-border
    Transaction Type
  • Germany | United Kingdom
    Countries

Meet our Senior Team